Cite
MLA Citation
L Peyrin-Biroulet et al.. “DOP90 Efficacy of the treat-to-target approach in modifying disease course with ustekinumab in patients with moderate-to-severe Crohn's Disease: Results from the STARDUST trial.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i132–i134. http://access.bl.uk/ark:/81055/vdc_100150515049.0x000018